Farmaci. Fda propone prima bozza di linee guida sull’uso dell’AI nello sviluppo dei medicinali
New FDA Panel Weighs In on Regulating Generative AI in Healthcare
FDA seeks AI tech to predict, detect Parkinson’s symptoms
FDA Embraces AI in Drug Development: A Leap Towards the Future with ISTAND
Congress Navigating The Future Of AI In Healthcare
La FDA concede la designazione di “breakthrough device” a un algoritmo di AI per la diagnosi dell’amiloidosi cardiaca
FDA encourages decentralized trials with new guidance
Wondering if Your Digital Health Product or Service is Subject to FDA Regulations?